About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Cohance Lifesciences Ltd.
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value
61.79
NSE Code
COHANCE
Dividend Yield %
0.00
Market Cap
335607.02
P/E
129.28
EPS
6.79
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
24-Oct-2025
886.05
908.00
874.00
877.25
6568
5817634
23-Oct-2025
893.95
904.10
880.20
885.50
123472
109984656
21-Oct-2025
872.20
917.50
872.20
899.70
18567
16663607
20-Oct-2025
912.30
912.30
873.00
878.75
7695
6782093
17-Oct-2025
893.20
896.95
881.40
891.10
8222
7305680
16-Oct-2025
875.95
900.10
874.30
898.05
6365
5662542
15-Oct-2025
867.15
875.00
864.95
869.10
3385
2943884
14-Oct-2025
884.85
884.90
865.10
866.40
4061
3554603
13-Oct-2025
891.75
899.25
882.50
885.15
6052
5381484
10-Oct-2025
881.75
907.00
876.05
904.80
21149
18983372
09-Oct-2025
863.15
884.35
863.15
881.70
5841
5102961
08-Oct-2025
868.30
872.25
857.00
860.95
8581
7406249
07-Oct-2025
869.65
875.95
866.00
875.00
8425
7359247
06-Oct-2025
873.70
875.50
865.80
868.70
5658
4935008
03-Oct-2025
870.50
879.90
870.15
873.55
7904
6912236
01-Oct-2025
883.65
883.65
866.30
870.10
2833
2480853
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.